A clinical trial for HIV/AIDS vaccine designed to evaluate non-neutralizing functions of vaccine-induced antibodies confirmed the correlation between HIV-specific antibodies and secretion of IFN-γ, CCL4 and expression of the degranulation marker CD107a on NK cells, from vaccine recipients (56). The gene discussed is IFNG; the disease is AIDS.